In mammalian cells, the level of estrogen receptor alpha (ER alpha) is rapidly decreased upon estrogen treatment, and this regulation involves proteasome degradation. Using different approaches, we showed that the Mdm2 oncogenic ubiquitin-ligase directly interacts with ER alpha in a ternary complex with p53 and is involved in the regulation of ER alpha turnover (both in the absence or presence of estrogens). Several lines of evidence indicated that this effect of Mdm2 required its ubiquitin-ligase activity and involved the ubiquitin/proteasome pathway. Moreover, in MCF-7 human breast cancer cells, various p53-inducing agents (such as UV irradiation) or treatment with RITA (which inhibits the interaction of p53 with Mdm2) stabilized ER alpha and abolished its 17 beta-estradiol-dependent turnover. Interestingly, our data indicated that ligand-dependent receptor turnover was not required for efficient transactivation. Altogether, our results indicate that the Mdm2 oncoprotein and stress-inducing agents complexly and differentially regulate ER alpha stability and transcriptional activity in human cancer cells.
Differential regulation of estrogen receptor alpha turnover and transactivation by Mdm2 and stress-inducing agents
Duong, V.; Boulle, N.; Daujat, S.; Chauvet, J.; Bonnet, S.; Neel, H.; Cavailles, V.
2007-06-01 / vol 67 / pages 5513-5521
tumor-suppressor; ubiquitin ligase; breast-cancer cells; dependent degradation; er-alpha; glucocorticoid-receptor; hormone-receptor; human progesterone; protein expression; transcriptional activity